We continue to see a remarkable stream of people transiting the revolving door
from high-level positions in health care corporations to high-level positions in health care policy or regulation for the
Trump administration. Lately, though, these transitions have not been without missteps.
The most recent cases we have found, in the order of their public appearance, appear below.
John
Home
»
conflicts of interest
»
CVS
»
Donald Trump
»
finance
»
health care corruption
»
Pfizer
»
revolving doors
» Through the Revolving Door, with a Few Stumbles - Health Care Corporate Executives and Consultants Continue to Become Leaders of Trump's Department of Health and Human Services
Subscribe to:
Post Comments (Atom)
Post a Comment